about
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
Read More
5.61
0.00
(0.00%)
10,086
XNAS Volume
XNAS 29 Aug, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Exicure Inc is on 04 Sep 2025 for the purpose of Exicure Inc Annual General Meeting for 2024
See details
Not Eligible
Expensive Valuation
Technically Bearish
Exicure Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..